Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
19
-
Total shares
-
671K
-
Shares change
-
-121K
-
Total reported value, excl. options
-
$10.2M
-
Value change
-
-$1.65M
-
Number of buys
-
8
-
Number of sells
-
-10
-
Price
-
$15.20
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q4 2022
19 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q4 2022.
Greenwich LifeSciences, Inc. - COM (GLSI) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 671K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (345K shares), AMERIPRISE FINANCIAL INC (65.7K shares), BlackRock Inc. (50.9K shares), MARSHALL WACE, LLP (42.5K shares), GEODE CAPITAL MANAGEMENT, LLC (39.9K shares), MILLENNIUM MANAGEMENT LLC (35.7K shares), RENAISSANCE TECHNOLOGIES LLC (33.3K shares), STATE STREET CORP (13K shares), GSA CAPITAL PARTNERS LLP (12.8K shares), and 683 Capital Management, LLC (11.7K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.